Maxine Gossell‐Williams
- Drug Discovery top 5%
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions 8
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes 6
- Pharmacology top 10%
-
- Pharmaceutical studies and practices 5
-
- Blood Pressure and Hypertension Studies 4
-
- Fatty Acid Research and Health 4
-
- Schizophrenia research and treatment 3
-
- Biosimilars and Bioanalytical Methods 3
-
- Pharmaceutical Economics and Policy 3
- Co-authors
- Aline M. DavisNathan O’ConnorHorace FletcherArkene LevyMichael GardnerDonovan McGrowderChristine WaltersCraig Hyde
- Partner nations
- JamaicaUnited StatesBarbados
In The Last Decade
Maxine Gossell‐Williams
46 papers receiving 552 citations
Peers
Comparison fields: 5 of 119
- Drug Discovery 4
- Toxicology 48
- Geriatrics and Gerontology 29
- Complementary and alternative medicine 60
- Pharmacology 61
Countries citing papers authored by Maxine Gossell‐Williams
This map shows the geographic impact of Maxine Gossell‐Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxine Gossell‐Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxine Gossell‐Williams more than expected).
Fields of papers citing papers by Maxine Gossell‐Williams
This network shows the impact of papers produced by Maxine Gossell‐Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxine Gossell‐Williams. The network helps show where Maxine Gossell‐Williams may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maxine Gossell‐Williams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 4 | |
| 4 | 2021 | 9 | |
| 5 | 2020 | 2 | |
| 6 | 2019 | 4 | |
| 7 | 2018 | 4 | |
| 8 | 2017 | 2 | |
| 9 | Statins Associated With Orthostatic Hypotension in the Aging Hypertensive Adult of Caribbean Descent and the Protective Benefits of Angiotensin Enzyme Inhibitors. | 2014 | 1 |
| 10 | 2014 | 47 | |
| 11 | 2012 | 21 | |
| 12 | 2011 | 34 | |
| 13 | 2008 | 47 | |
| 14 | 2008 | 1 | |
| 15 | 2008 | 7 | |
| 16 | 2006 | 112 | |
| 17 | 2006 | 3 | |
| 18 | 2006 | 43 | |
| 19 | 2005 | 44 | |
| 20 | 1999 | 3 |
About Maxine Gossell‐Williams
Maxine Gossell‐Williams is a scholar working on Toxicology, Geriatrics and Gerontology and Applied Microbiology and Biotechnology, having authored 53 papers that have together received 601 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmaceutical Practices and Patient Outcomes (6 papers), Pharmaceutical studies and practices (5 papers), Blood Pressure and Hypertension Studies (4 papers), Fatty Acid Research and Health (4 papers), Schizophrenia research and treatment (3 papers), Biosimilars and Bioanalytical Methods (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Drug Discovery (4 citations), Toxicology (48 citations) and Geriatrics and Gerontology (29 citations). Maxine Gossell‐Williams has collaborated with scholars based in Jamaica, United States and Barbados. Frequent co-authors include Aline M. Davis, Nathan O’Connor, Horace Fletcher, Arkene Levy, Michael Gardner, Donovan McGrowder, Christine Walters, Craig Hyde, E N Barton and Amusa S. Adebayo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.